Core Insights - PetIQ, Inc. announces the appointment of Camillo Pane as the new Chief Executive Officer, effective February 17, 2025, succeeding Cord Christensen [2][3] - Camillo Pane brings over 30 years of leadership experience in consumer goods and health sectors, having previously served as Group CEO of Health & Happiness Group and CEO of Coty [3][4] - PetIQ aims to enhance access to affordable veterinary services and expand its health product offerings for pets under Pane's leadership [4][5] Company Overview - PetIQ is a leading company in pet medication, health, and wellness, providing convenient access to affordable products and veterinary services [5] - The company operates over 2,600 mobile community clinic locations and wellness centers across 39 states [5] - PetIQ manufactures and distributes pet products from facilities located in Omaha, Nebraska; Springville, Utah; and Daytona Beach, Florida [5]

Core Points - PetIQ, Inc. has completed its acquisition by Bansk Group in an all-cash transaction valued at approximately $1.5 billion, with stockholders receiving $31.00 per share [1] - Following the acquisition, PetIQ will be delisted from the Nasdaq stock exchange and will operate as a privately held company [1] Company Overview - PetIQ is a leading company in pet medication, health, and wellness, providing affordable products and veterinary services through retail and e-commerce channels [4] - The company operates over 2,600 mobile community clinic locations and wellness centers across 39 states [4] Bansk Group Overview - Bansk Group, founded in 2019, focuses on investing in distinctive consumer brands across various categories, including beauty, health, food, and household products [5] - The firm has a history of over $30 billion in equity capital investments across more than 40 transactions in the consumer sector [5] Strategic Vision - PetIQ aims to enhance its capabilities and offerings for pet parents through strategic investments in marketing and innovation, as well as potential acquisitions [2][5] - Bansk Group expresses confidence in PetIQ's growth potential within the pet health and wellness category, emphasizing a commitment to support the company's next phase of growth [2]

EAGLE, Idaho, Oct. 22, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, announced today that at its virtual Special Meeting of Stockholders approximately 80% of its outstanding shares of common stock voted to approve the adoption of the definitive merger agreement (the “Agreement”) pursuant to which Bansk Group will acquire all of the outstanding shares of PetIQ’s common stock for $31.00 per share, in an all-cash transacti ...

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, inves ...

PetIQ (PETQ) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Indivi ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies. Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors rely o ...

Have you been paying attention to shares of PetIQ (PETQ) ? Shares have been on the move with the stock up 0.5% over the past month. The stock hit a new 52-week high of $30.77 in the previous session. PetIQ has gained 55.1% since the start of the year compared to the 10.7% move for the Zacks Medical sector and the 14.6% return for the Zacks Medical - Products industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consen ...

NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating PetIQ, Inc. (Nasdaq: PETQ), relating to its proposed merger with Bansk Group. Under the terms of the agreement, PetIQ shares will be automatically converted into the right to receive $31.00 in ...

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: PetIQ, Inc. (NASDAQ: PETQ)'s merger with Bansk Group for $31.00 per share. If you are a PetIQ shareholder, click here to learn more about your legal rights and options. Dril-Quip, Inc. (NYSE: DRQ)'s merger with Innovex Downhole Solutions, Inc. Upon closing of ...

Core Viewpoint - PetIQ (PETQ) reported quarterly earnings of $0.70 per share, exceeding the Zacks Consensus Estimate of $0.49 per share, and showing an increase from $0.46 per share a year ago, representing an earnings surprise of 42.86% [1] Financial Performance - The company posted revenues of $291.2 million for the quarter ended June 2024, which was 12.02% below the Zacks Consensus Estimate and a decrease from $314.55 million year-over-year [2] - Over the last four quarters, PetIQ has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Performance - PetIQ shares have increased approximately 4.2% since the beginning of the year, while the S&P 500 has gained 9.9% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.37 on revenues of $288.17 million, and for the current fiscal year, it is $1.42 on revenues of $1.16 billion [7] - The estimate revisions trend for PetIQ is mixed, and future changes in estimates will be closely monitored following the recent earnings report [6][7] Industry Context - The Medical - Products industry, to which PetIQ belongs, is currently ranked in the top 42% of over 250 Zacks industries, suggesting that companies in the top half tend to outperform those in the bottom half by more than 2 to 1 [8]